UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 5 von 196
Datensatz exportieren als...
BibTeX
A New clinical score for disease activity in Langerhans cell histiocytosis
Pediatric Blood & Cancer, 2004-12, Vol.43 (7), p.770-776
Donadieu, Jean
Piguet, C.
Bernard, F.
Barkaoui, M.
Ouache, M.
Bertrand, Y.
Ibrahim, H.
Emile, J.F.
Hermine, O.
Tazi, A.
Genereau, T.
Thomas, C.
2004
Details
Autor(en) / Beteiligte
Donadieu, Jean
Piguet, C.
Bernard, F.
Barkaoui, M.
Ouache, M.
Bertrand, Y.
Ibrahim, H.
Emile, J.F.
Hermine, O.
Tazi, A.
Genereau, T.
Thomas, C.
Titel
A New clinical score for disease activity in Langerhans cell histiocytosis
Ist Teil von
Pediatric Blood & Cancer, 2004-12, Vol.43 (7), p.770-776
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2004
Link zum Volltext
Quelle
Wiley-Blackwell Full Collection
Beschreibungen/Notizen
Objective To develop an objective tool for assessing disease activity in patients with Langerhans cell histiocytosis (LCH). Method Scoring system was developed and applied to a database containing information on 612 patients. Results At diagnosis, the score distribution was highly asymmetrical: the score was between 0 and 2 in 74% of cases, 3–6 in 16%, 7–10 in 3%, and more than 10 in 6%. The 5‐year mortality rates were 1, 4.4, and 43.4%, respectively, among patients with initial scores of 0–2, 3‐6, and >6. Stability or an increase of the score at 6 weeks was highly predictive of death among patients with initial scores above 6, while score stability had no significant impact on vital outcome among patients with low or moderate scores at diagnosis. Conclusions This LCH disease activity score provides an objective tool for assessing disease severity, both at diagnosis and during follow‐up and treatment. © 2004 Wiley‐Liss, Inc.
Sprache
Englisch
Identifikatoren
ISSN: 1545-5009
eISSN: 1545-5017
DOI: 10.1002/pbc.20160
Titel-ID: cdi_proquest_miscellaneous_67036956
Format
–
Schlagworte
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
,
Biological and medical sciences
,
Data Interpretation, Statistical
,
Databases, Factual
,
General aspects
,
Histiocytosis, Langerhans-Cell - diagnosis
,
Histiocytosis, Langerhans-Cell - drug therapy
,
Histiocytosis, Langerhans-Cell - mortality
,
Humans
,
Langerhans cell histiocytosis
,
Medical sciences
,
Predictive Value of Tests
,
prognostic factors
,
score
,
Severity of Illness Index
,
Statistical Distributions
,
Survival Analysis
,
therapeutic evaluation
,
Time Factors
,
Tumors
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX